Lateral Flow Assay Market Size, Share & Trends Analysis Report By Type (Kits & Reagents, Lateral Flow Readers), By Application, By Technique, By Sample Type, By End Users, By Region, And By Segment Forecasts, 2023-2031.
Lateral Flow Assay Market Size is valued at USD 20.65 Bn in 2023 and is predicted to reach USD 24.45 Bn by the year 2031 at a 2.21% CAGR during the forecast period for 2024-2031.
Immunochromatographic tests, known as lateral flow assays, can determine if a target analyte, such as a pathogen or a biomarker, is present or absent in people or animals. Due to increased usage in medical diagnostics, a rise in the occurrence of infectious diseases, the increasing need for point-of-care testing, and the widespread acceptance of home-based lateral flow assay tests. In terms of sensitivity, selectivity, and quantification advancements, technological growth is causing lateral flow tests to work better. Manufacturers' test readers are frequently utilized to assess the robustness of a sample's test line. Portable lateral flow assay readers are becoming increasingly popular due to their expanding mobility and downsizing. Technological advancements in using various wavelengths for sample illumination and various sample detection systems, which use CMOS or CCD detecting technologies, are driving innovations in lateral flow assay testing equipment.
Furthermore, assays are evolving from straightforward qualitative tests to intricate multi-analyte quantitative assays, driving the growth of the lateral flow assay market. The substantial incidence of infectious diseases, the growing geriatric population, the rising demand for point-of-care testing, the rising demand for home-based lateral flow assay test kits, and the rising disposable income in developing nations are the main factors driving the global lateral flow assay market. The global market is expected to be driven by technological development and rising product usage. The demand for user-friendly point-of-care testing in-home care settings that can provide results in real-time (5-15 minutes) is rising due to the increased frequency of infectious and lifestyle diseases.
Competitive Landscape
Some Major Key Players In The Lateral Flow Assay Market:
- Abbott Laboratories (US),
- Quidel Corporation (US),
- Hoffman-La Roche AG (Switzerland),
- Danaher Corporation (US),
- Siemens AG (Germany),
- BD (US),
- bioMérieux SA (France),
- Thermo Fisher Scientific, Inc. (US),
- PerkinElmer Inc. (US),
- Hologic Inc. (US),
- QIAGEN N.V. (Netherlands),
- Merck KGaA (Germany).
- Abcam Plc
- Surmodics, Inc.
- Chembio Diagnostics, Inc.
- Orasure Technologies
- Dcn Diagnostics
- Polysciences Inc.
- Abingdon Health
- Oranoxis Inc.
- Group Gmbh
- Bio Group Medical System S.R.L
- Pharmact Gmbh
- Diesse Diagnostica Senese S.P.A.
- Xiamen Biotime Biotechnology Co., Ltd.
- Others
Market Segmentation:
The Lateral Flow Assay market segmentation is on the basis of type, application, technique, sample type and end users. Based on type, the market is segmented as kits & reagents and lateral flow readers. As per the application, the market is divided into clinical testing, veterinary diagnostics, food safety & environment testing and drug development & quality testing. By technique, the market is segmented into sandwich assay, competitive assays and multiplex detection assays. According to sample type, the market is divided into Blood Samples, Urine Samples, Saliva Samples and Others Samples. The end users segmentation compriseshospitals & clinics, diagnostic laboratories, home care, pharmaceutical & biotechnology companies and other end users.
Based On Product, The Kits & Reagents Segment Is A Major Contributor In The Lateral Flow Assay Market.
The kits & reagents category will hold a major share of the world lateral flow assay market in 2022 due to the spread of infectious diseases and the expanding usage of lateral flow kits in home care settings. To improve the creation of efficient and sensitive lateral flow test instruments, Newmarket participants are working together. As a result, the market is projected that the demand for lateral flow assays will expand throughout the projection period due to increased strategic collaborations to accelerate the development of lateral flow kits.
The Sandwich Assay Technique Segment Witnessed Growth At A Rapid Rate.
The sandwich assay technique segment is projected to grow rapidly in the global lateral flow assay market owing to growing concerns about the harmful effects of synthetic chemicals on the skin. Hence, with the growing popularity of bio-based beauty products and personal hygiene products, there is an increase in demand for lateral flow assay in the personal care sector, especially in countries such as the US, Germany, the UK, China, and India.
The North American Lateral Flow Assay Market Holds A Significant Regional Revenue Share.
The North America lateral flow assay market is expected to record the maximum market share in revenue shortly. As the increase in chronic disease prevalence, the rise in requirement for home health care, the early adoption of test procedures, and the existence of many important stakeholders. In addition, Asia Pacific is estimated to grow rapidly in the global lateral flow assay market. Due to a huge patient pool, increased government initiatives to provide improved healthcare facilities, a growth in disposable money, and increased public knowledge.
Recent Developments:
- In Feb 2021, A partnership was established between BD (Becton, Dickinson and Company) and Scanwell Health with the aim of developing an in-home fast test for SARS-CoV-2. This will be achieved by utilising a BD antigen test in conjunction with the Scanwell Health mobile application.
Lateral Flow Assay Market Report Scope
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 20.65 Bn |
| Revenue Forecast In 2031 | USD 24.45 Bn |
| Growth Rate CAGR | CAGR of 2.21% from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Type, By Application, By Technique, By Sample Type, By End Users |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | Abbott Laboratories (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Germany), PerkinElmer Inc. (U.S.), Quidel Corporation (U.S.), Merck KGAA (Germany), Abcam Plc, Surmodics, Inc., Chembio Diagnostics, Inc., Orasure Technologies, DCN Diagnostics, Polysciences Inc., Abingdon Health, Oranoxis Inc., Aesku.Group Gmbh, Bio Group Medical System S.R.L, Pharmact Gmbh, Diesse Diagnostica Senese S.P.A., Xiamen Biotime Biotechnology Co., Ltd. |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Lateral Flow Assay Market -
By Type-
- Kits & Reagents
- Lateral Flow Readers
Lateral Flow Assay Market By Application-
- Clinical Testing
- Veterinary Diagnostics
- Food Safety & Environment Testing
- Drug Development & Quality Testing
Lateral Flow Assay Market By Technique
- Sandwich Assays
- Competitive Assays
- Multiplex Detection Assays
Lateral Flow Assay Market By Sample type
- Blood Samples
- Urine Samples
- Saliva Samples
- Others Samples
Lateral Flow Assay Market By End Users
- Hospitals & Clinics
- Diagnostic Laboratories
- Home Care
- Pharmaceutical & Biotechnology Companies
- Other End Users (Water Treatment Facilities and Food Processing Units)
Lateral Flow Assay Market By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Lateral Flow Assay Market Size is valued at USD 20.65 Bn in 2023 and is predicted to reach USD 24.45 Bn by the year 2031
Lateral Flow Assay Market is expected to grow at a 2.21% CAGR during the forecast period for 2024-2031.
Chembio Diagnostics, Inc., Orasure Technologies, DCN Diagnostics, Polysciences Inc., Abingdon Health, Oranoxis Inc., Aesku.Group Gmbh, Bio Group Medic